Expression of the RAI gene is conducive to apoptosis: Studies of induction and interference

Experimental Cell Research

Volumn 313, Issue 12, 2007, Pages 2611-2621

  Laska, Magdalena J ^a   Strandbygård, Dorthe ^a   Kjeldgaard, Anette ^a   Mains, Mette ^a   Corydon, Thomas J ^a   Memon, Ashfaque A ^b   Sørensen, Boe S ^b   Vogel, Ulla ^c   Jensen, Uffe B ^a,b   Nexø, Bjørn A ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

Apoptosis; Etoposide VP 16; Gene RAI; Lymphocytes; NF B

Indexed keywords

CALCIUM ION; ETOPOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; MESSENGER RNA; REGULATOR PROTEIN; RELA ASSOCIATED INHIBITOR; SALAZOSULFAPYRIDINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRAIN HEK293; CELL TRANSFORMATION; CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAI GENE; SERUM; TUMOR SUPPRESSOR GENE;

EID: 34250816848     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.05.006     Document Type: Article

References (16)

1. Dybdahl M., Frentz G., Vogel U., Wallin H., and Nexø B.A. Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients. Mutat. Res. 433 (1999) 15-22
2. Rockenbauer E., Bendixen M.H., Bukowy Z., Yin J., Jacobsen N.R., Hedayati M.A., Vogel U., Grossman L., Bolund L., and Nexø B.A. Association of chromosome 19q13.2-3 with basal cell carcinoma: tentative delineation of an involved region using data for single nucleotide polymorphisms in two cohorts. Carcinogenesis 23 (2002) 1149-1153
3. Nexø B.A., Vogel U., Olsen A., Ketelsen T., Bukowy Z., Thomsen B.L., Wallin H., Overvad K., and Tjønneland A. A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the genes RAI is indicative of postmenopausal breast cancer before age 55. Carcinogenesis 24 (2003) 899-904
4. Vogel U., Laros I., Jacobsen N.R., Thomsen B., Bak H., Olsen A., Bukowy Z., Wallin H., Overvad K., Tjønneland A., Nexø B.A., and Raaschou-Nielsen O. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat. Res. 546 (2004) 65-74
5. Yang J.P., Hori M., Sanda T., and Okamoto T. Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J. Biol. Chem. 274 (1999) 15662-15670
6. Takada N., Sanda T., Okamoto H., Yang J.P., Asamitsu K., Sarol L., Kimura G., Uranishi H., Tetsuka T., and Okamoto T. RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actions. J. Virol. 76 (2002) 8019-8030
7. Bergamaschi D., Samuels Y., O'Neil N.J., Trigiante G., Crook T., Hsieh J.K., O'Conner D.J., Zhong S., Campargue I., Tomlinson M.L., Kuwabara P.E., and Lu X. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat. Genet. 33 (2003) 162-167
8. Slee E.A., Gillotin S., Bergamaschi D., Rover C., Llanos S., Ali S., Jin B., Trigiante G., and Lu X. The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization. Oncogene 23 (2004) 9007-9016
9. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37 (1965) 614-636
10. Hayflick L., and Moorehead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25 (1961) 585-621
11. Graham F.L., Smiley J., Russell W.C., and Nair R. Characteristics of human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36 (1997) 59-74
12. Ritke M.K., Rusnak J.M., Lazo J.S., Allan W.P., Dive C., Heer S., and Yalowich J.C. Differential induction of Etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Mol. Pharmacol. 46 (1994) 605-611
13. Barkett M., and Gilmore T.D. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18 (1999) 6910-6924
14. van Waes C. Nuclear factor-κB in development, prevention and therapy of cancer. Clin. Cancer Res. 13 (2007) 1076-1082
15. Arlt A., and Vorndamn J. Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide VP-16 or doxorubicin. Oncogene 20 (2001) 859-868
16. Wang C.Y., Guttridge D.C., Mayo M.W., and Baldwin Jr. A.S. NF-κB induces expression of the Bcl-2 homolog A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. (1999) 5929-5934